CLINICAL_TRIALS
trial_result
· 2014-12-01
Clinical Trial Update: Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) [Phase 3]
Summary
Phase 3 trial update for sorafenib as adjuvant therapy in hepatocellular carcinoma (STORM) completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED | Results posted: 2014-12-01